Journal profile · Microbiology
Helicobacter
ISSN 1083-4389 · eISSN 1523-5378 · Wiley-Blackwell Publishing Ltd · UNITED STATES · Quarterly · Founded 1996
Helicobacter: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.47; hybrid open access; APC about USD 4,150; median 72 days to acceptance (90 articles, last 24 months); community-reported acceptance: moderate; 100 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Helicobacter is published by Wiley-Blackwell Publishing Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Helicobacter pylori-related gastroenterology studies, Microscopic Colitis and Clostridium difficile and Clostridium perfringens research, together about 55.8% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Helicobacter is edited by Professor David Y Graham. The editorial and peer review process is an independent process. Whenever there is a conflict of interest, the editor and editorial board will declare their interests and affiliations. Helicobacter recognises the critical role that has been established for Helicobacter pylori in peptic ulcer, gastric adenocarcinoma, and primary gastric lymphoma. As new helicobacter species are now regularly being discovered, Helicobacter covers the entire range of helicobacter research, increasing communication among the fields of • gastroenterology • microbiology • vaccine development • laboratory animal science. New discoveries in molecular biology and clinical trials of new treatment open up a wide range of possibilities for patient care and cure — Helicobacter will be there to report the results. From the 2011 volume, Helicobacter will be published in an online-only format.
From the journal's Aims & Scope
Research area (LetPub): Microbiology
Editor-in-chief Wai-Keung LeungPublisher website
Editorial board by country: none in mainland China; most named Australia 2, Hong Kong, China 1 (3 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Helicobacter pylori-related gastroenterology studiesMedicine38.6%
- Microscopic ColitisMedicine9.2%
- Clostridium difficile and Clostridium perfringens researchMedicine8%
- Gastric Cancer Management and OutcomesMedicine5.3%
- Eosinophilic EsophagitisMedicine4.9%
- Gastroesophageal reflux and treatmentsMedicine4.1%
- Gastrointestinal motility and disordersMedicine3.1%
- Whipple's Disease and InterleukinsMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Microbiology | Zone 2 |
| Minor | Gastroenterology & Hepatology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Gastroenterology & Hepatology | Zone 2 |
| Minor | Microbiology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Microbiology | Zone 2 |
| Minor | Gastroenterology & Hepatology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.47LetPub ·
- Impact factor (publisher)
- 4.6Publisher website ·
- Impact factor (publisher) 2025
- 4.6Publisher website ·
- CiteScore 2026-06
- 8LetPub ·
- CiteScore (publisher)
- 8Publisher website ·
- CiteScore (publisher) 2025
- 8Publisher website ·
- SJR 2026-06
- 1.08LetPub ·
- SNIP 2026-06
- 1.1LetPub ·
- h-index
- 71LetPub ·
- h-index
- 108OpenAlex ·
- i10-index
- 1,749OpenAlex ·
- 2-year mean citedness
- 4.74OpenAlex ·
- Self-citation rate
- 6.5%LetPub ·
- Share of gold OA articles
- 27.04%LetPub ·
Volume
- Articles per year
- 77LetPub ·
- Articles per year (publisher) 2025
- 87Publisher website ·
- Downloads per year (publisher) 2025
- 236,492Publisher website ·
Articles by year OpenAlex count · 2,907 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 68 | 32 | 67 |
| 2025 | 100 | 50 | 344 |
| 2024 | 125 | 71 | 979 |
| 2023 | 105 | 57 | 1,516 |
| 2022 | 82 | 20 | 1,352 |
| 2021 | 97 | 14 | 1,796 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
72 daysMedian, submission to acceptance · P25–P75 48 days – 118 days
- Acceptance to online
- median 16 days (90 articles)
- Submission to online
- median 92 days
- Sample
- 90 articles with submission and acceptance dates (174 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Acceptance rate (publisher)
- 16%Publisher website ·
- Acceptance rate (publisher) 2025
- 16%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- Submission to first decision 2025
- 3 daysPublisher website ·
- Submission to acceptance 2025
- 75 daysPublisher website ·
- Acceptance to publication 2025
- 13 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / EUR 3,470 / GBP 2,720 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 300 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Optional
- Cover letter
- Required
- Not considered
- case reports
Article types accepted5
- brief communicationManuscripts will be considered for publication in the form of original articles, reviews, descriptions of techniques, brief communications, and letters. We acce…Length not stated
- case reportManuscripts will be considered for publication in the form of original articles, reviews, descriptions of techniques, brief communications, and letters. We acce…Length not stated
- letterManuscripts will be considered for publication in the form of original articles, reviews, descriptions of techniques, brief communications, and letters. We acce…Length not stated
- original articleManuscripts will be considered for publication in the form of original articles, reviews, descriptions of techniques, brief communications, and letters. We acce…Length not stated
- reviewManuscripts will be considered for publication in the form of original articles, reviews, descriptions of techniques, brief communications, and letters. We acce…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use Artificial Intelligence Generated Content:
Wiley’s guidance on artificial intelligence generated content (such as ChatGPT) is available here. If an author has used Artificial intelligence generated content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)— to develop any portion of your manuscript, its use must be described, transparently and in detail, in the Methods or Acknowledgements section.
Source ↗Publisher website ·- Authorship Authorship
Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.ORCID
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.
Source ↗Publisher website ·- Publication ethics Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.Correction to authorship
Source ↗Publisher website ·- Open access Open Access Publishing
Open access is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With open access, the author, the author's funding agency, or the author's institution pays a fee (APC) to ensure that the article is made available to non-subscribers up…
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
The acceptance criteria for all papers is the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. Wiley's policy on confidentiality of the review process i…
Source ↗Publisher website ·- Preprints Preprint Policy
Helicobacter will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.Recommended Reviewers
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1996
- ISSN
- 1083-4389
- Electronic ISSN
- 1523-5378
- Latest issue on the website
- Volume 31, Issue 5 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Helicobacter
What CAS zone is Helicobacter in?
In the 2025 upgraded edition of the CAS Journal Ranking, Helicobacter is in Zone 2 of Medicine, and in Zone 2 of the minor category Microbiology / Gastroenterology & Hepatology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Helicobacter?
The latest impact factor listed by LetPub is 4.47; CiteScore 8, h-index 108.
How long does peer review take at Helicobacter?
Based on the dates recorded on 90 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 72 days (interquartile range 48–118 days); authors report an average review time of about 2 months; the community-reported acceptance is “Moderate”; the journal's website gives an acceptance rate of 16% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Helicobacter?
According to the journal's author guidelines: Abstract: ≤ 300 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Helicobacter based?
Of the 3 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Australia (2) and Hong Kong, China (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Helicobacter?
According to LetPub and DOAJ records, Helicobacter is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Helicobacter open access, and what is the APC?
Helicobacter is a hybrid journal. For open-access publication: APC about USD 4,150.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .